Kalaris Therapeutics, Inc. (KLRS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
KLRS currently has 23.7M outstanding shares. with significant dilution risk as 70.6M authorized shares could dilute existing holders by 297.6%. The company has significantly diluted shareholders by 299.84% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 23.7M shares outstanding |
24M | 71M |
| Apr 03, 2026 |
S-3 filing: The company intends to offer and sell debt securities, common stock, preferred stock and subscription rights from time to time in one or more offerings of up to $350,000,000 in aggregate offering price. |
23M | 71M |
| Apr 03, 2026 |
S-3 filing: This prospectus relates to the resale from time to time of up to 5,000,000 shares of common stock of Kalaris Therapeutics, Inc. by the selling stockholders. |
23M | 53M |
| Mar 17, 2026 |
10-K filing | 22.9M shares outstanding |
23M | 48M |
| Aug 13, 2025 |
10-Q filing | 18.7M shares outstanding |
19M | 48M |
| May 14, 2025 |
10-Q filing | 18.7M shares outstanding |
19M | 48M |
| Mar 07, 2025 |
10-K filing | 5.0M shares outstanding |
5M | 48M |
| Nov 12, 2024 |
10-Q filing | 115.4M shares outstanding |
120M | 48M |
| Aug 09, 2024 |
10-Q filing | 115.1M shares outstanding |
120M | 48M |
| May 13, 2024 |
10-Q filing | 114.7M shares outstanding |
110M | 48M |
| Mar 15, 2024 |
10-K filing | 104.1M shares outstanding |
100M | 48M |
| Nov 02, 2023 |
10-Q filing | 113.9M shares outstanding |
110M | 48M |
| Aug 03, 2023 |
10-Q filing | 113.9M shares outstanding |
110M | 48M |
| May 04, 2023 |
10-Q filing | 93.3M shares outstanding |
93M | 48M |
| Feb 15, 2023 |
S-3 filing: This prospectus relates to the proposed resale, from time to time, by the selling stockholders identified in this prospectus of up to 31,359,683 shares of our common stock, par value $0.0001 per share. |
93M | 48M |
| Feb 15, 2023 |
10-K filing | 93.5M shares outstanding |
93M | 48M |
| Nov 03, 2022 |
10-Q filing | 84.9M shares outstanding |
85M | 17M |
| Aug 04, 2022 |
10-Q filing | 93.1M shares outstanding |
93M | 17M |
| May 05, 2022 |
10-Q filing | 65.4M shares outstanding |
65M | 17M |
| Feb 10, 2022 |
10-K filing | 65.3M shares outstanding |
65M | 17M |
| Feb 10, 2022 |
POS AM filing: The filing is a POS AM for a shelf offering of common stock, preferred stock, and debt securities, with a total aggregate amount not to exceed $250,000,000. |
65M | 17M |
| Nov 05, 2021 |
10-Q filing | 65.1M shares outstanding |
65M | 17M |
| Aug 06, 2021 |
10-Q filing | 65.1M shares outstanding |
65M | 17M |
| May 06, 2021 |
10-Q filing | 65.1M shares outstanding |
65M | 17M |
| Feb 12, 2021 |
10-K filing | 65.1M shares outstanding |
65M | 17M |
| Nov 10, 2020 |
10-Q filing | 65.1M shares outstanding |
65M | 17M |
| Sep 02, 2020 |
10-Q filing | 21.6M shares outstanding |
22M | 17M |
| Jul 23, 2020 |
S-1/A filing: This S-1/A filing from 2020-07-23 describes an initial public offering of common stock at $17.00 per share, with 14,750,000 shares offered and an option for underwriters to purchase an additional 2,212,500 shares. |
61M | 17M |